Edgewise Therapeutics, Inc..
EWTX.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing orally administered, small molecule therapeutics for severe, inherited muscle disorders. Their lead product candidate, EDG-5506, is designed to address the root cause of dystrophinopathies, such as Duchen...Show More
Better Health for All
0
No evidence available to assess Edgewise Therapeutics, Inc. on Better Health for All.
Fair Money & Economic Opportunity
0
No evidence available to assess Edgewise Therapeutics, Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
No specific, concrete data points were found in the provided articles for any of the KPIs under the 'Fair Pay & Worker Respect' value. While executive compensation details were available, median employee compensation was not, preventing the calculation of the CEO median pay ratio.
1
All other relevant metrics were explicitly noted as 'Metrics Not Found' or were not present in the accessible articles.
2
Fair Trade & Ethical Sourcing
0
No evidence available to assess Edgewise Therapeutics, Inc. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
0
No specific quantitative data or concrete evidence was found across the provided articles for any of the KPIs related to Honest & Fair Business. The documents primarily outline corporate governance guidelines and committee charters. For instance, the Audit Committee Charter, adopted on February 26, 2021, and amended on November 9, 2023, details the committee's purpose, composition, and responsibilities, including oversight of financial reporting, internal controls, the independent auditor, and addressing complaints.
1
It also specifies that Audit Committee members must meet independence standards.
2
However, no metrics on regulatory fines, transparency index scores, whistleblower policy strength, financial restatements, audit coverage percentage, ESG controversy scores, complaint resolution times, board conflict-free percentages, anti-corruption policy enforcement, or third-party verification were available.
Kind to Animals
0
No specific, concrete evidence was found in the provided articles to score Edgewise Therapeutics, Inc. against any of the 'Kind to Animals' KPIs. The articles did not contain information regarding cruelty-free certifications, alternative testing usage, humane certifications for operations, wildlife conservation impact, ethical input substitution, supplier audits for welfare, cage-free sourcing, animal testing policy, animal testing volume, innovation investment in animal-free technologies, animal agriculture ethics, animal-free R&D collaboration, or public policy engagement related to animal welfare for Edgewise Therapeutics, Inc.
1
No War, No Weapons
0
No evidence available to assess Edgewise Therapeutics, Inc. on No War, No Weapons.
Planet-Friendly Business
0
No specific quantitative data related to Edgewise Therapeutics' environmental performance or planet-friendly business practices is provided across the articles.
1
The company does not report on key sustainability metrics such as emissions, renewable energy use, water consumption, or waste diversion.
2
While an overall ESG Risk Rating of 34.7 (High) is noted, the source explicitly states that no specific sustainability metrics are available or rated for the company.
3
Respect for Cultures & Communities
0
No information regarding Edgewise Therapeutics, Inc. or its practices related to Respect for Cultures & Communities was available in the provided article.
1
The URL led to a parked domain, and no data could be extracted for any of the requested metrics.
2
Safe & Smart Tech
0
The company states that, to its knowledge, there have been no breaches, violations, or unauthorized acquisitions of IT systems and company data in the past three years that would have a material adverse effect or require notification, with any minor incidents having been remedied without material cost or liability.
1
The company has experienced cybersecurity incidents in the past but states they were not materially impacted.
2
Edgewise Therapeutics states it has implemented and maintained commercially reasonable controls, policies, procedures, and safeguards to protect confidential information and IT systems for the past three years, and processes for detecting and responding to potential incidents are described.
3
The company's privacy policy outlines user rights to access, correct, delete data, and opt-out of processing.
4
Employees are trained on cybersecurity policies, and all new employees must acknowledge they have read and understand the Code of Business Conduct and Ethics.
5
The company's privacy policy mentions data retention based on purpose and legal requirements, and states it has put in place organizational and technical safeguards consistent with legal obligations and industry practices.
6
The company states it is in compliance with applicable state and federal data privacy and security laws and regulations, including HIPAA, HITECH Act, GDPR, and UK GDPR, and has a DPO Centre representative for the EEA and UK.
7
The board of directors discusses cybersecurity with management to prepare for new developments.
8
The company's IT systems are adequate and operate as required, to the company's knowledge, free of material bugs or malware.
9
Processes for identifying and mitigating vulnerabilities are in place, and security systems testing is mentioned.
10
Zero Waste & Sustainable Products
0
No evidence available to assess Edgewise Therapeutics, Inc. on Zero Waste & Sustainable Products.